Skip to content

Drug interactions

Eribulin + Nilotinib

Severity: Major

Eribulin and Nilotinib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nilotinib carries a boxed warning for QT prolongation and sudden death, and eribulin can also lengthen the QT interval. Together they may enhance the risk of serious ventricular arrhythmias including torsades de pointes.

What this interaction means in plain words

Eribulin and Nilotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Eribulin belongs to Oncology; Nilotinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Prefer an alternative to one of the agents; if concurrent use is necessary, perform baseline and periodic ECG monitoring and keep potassium and magnesium within normal range.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eribulin and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eribulin with Nilotinib?

MediHelp rates the interaction as major. Eribulin and Nilotinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Nilotinib carries a boxed warning for QT prolongation and sudden death, and eribulin can also lengthen the QT interval. Together they may enhance the risk of serious ventricular arrhythmias including torsades de pointes.

How serious is the interaction between Eribulin and Nilotinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer an alternative to one of the agents; if concurrent use is necessary, perform baseline and periodic ECG monitoring and keep potassium and magnesium within normal range.

What other medicines interact with Eribulin?

MediHelp also lists interactions of Eribulin with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Eribulin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in